These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12622712)

  • 1. Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
    Segawa N; Gohji K; Azuma H; Iwamoto Y; Ohnishi K; Katsuoka Y
    Int J Urol; 2003 Mar; 10(3):153-9. PubMed ID: 12622712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in renal cell carcinoma.
    Yoshida K; Sakamoto S; Sumi S; Higashi Y; Kitahara S
    Cancer; 1998 Aug; 83(4):760-6. PubMed ID: 9708942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity in human renal cell carcinoma.
    Fujioka T; Hasegawa M; Suzuki Y; Suzuki T; Sugimura J; Tanji S; Koike H
    Int J Urol; 2000 Jan; 7(1):16-21. PubMed ID: 10701886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human renal cell carcinoma.
    Sugimura K; Yoshida N; Hisatomi H; Nakatani T; Ikemoto S
    BJU Int; 1999 Apr; 83(6):693-7. PubMed ID: 10233581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
    Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O
    J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
    Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
    Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in malignant and benign renal tumors.
    Müller M; Heicappell R; Krause H; Sachsinger J; Porsche C; Miller K
    Eur Urol; 1999; 35(3):249-55. PubMed ID: 10072629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
    Hara T; Noma T; Yamashiro Y; Naito K; Nakazawa A
    Urol Res; 2001 Feb; 29(1):1-6. PubMed ID: 11310208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes and telomerase activity in human renal cell carcinoma.
    Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
    Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.
    Izumi H; Hara T; Oga A; Matsuda K; Sato Y; Naito K; Sasaki K
    Neoplasia; 2002; 4(2):103-11. PubMed ID: 11896565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of telomerase activity in multifocal renal cell carcinoma.
    Schlichter A; Fiedler W; Junker K; Dahse R; Claussen U; Schubert J
    Int J Oncol; 1999 Sep; 15(3):577-81. PubMed ID: 10427143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in human urothelial tumors.
    Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
    Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
    Mekhail TM; Kawanishi-Tabata R; Tubbs R; Novick A; Elson P; Ganapathi R; Ganapathi M; Bukowski R
    Urol Oncol; 2003; 21(6):424-30. PubMed ID: 14693268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.
    Szatmari I; Aradi J
    Nucleic Acids Res; 2001 Jan; 29(2):E3. PubMed ID: 11139633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
    Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
    J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of wnt-5a in human renal cell carcinoma cells suppresses in vitro growth and telomerase activity.
    Olson DJ; Oshimura M; Otte AP; Kumar R
    Tumour Biol; 1998; 19(4):244-52. PubMed ID: 9679734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.